In addition, inhibition of miR-34a also results in enhanced cardiomyocyte proliferation and improved cardiac function after MI by regulating silent information regulator factor 2 related enzyme 1 (Sirt1), B-cell lymphoma 2 (Bcl2) and Cyclin D1 [196]. This evidence concerns the gene CCND1 and myocardial infarction.